Market Cap 4.14M
Revenue (ttm) 0.00
Net Income (ttm) -15.85M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 23,800
Avg Vol 1,759,956
Day's Range N/A - N/A
Shares Out 811,000.00
Stochastic %K 15%
Beta 2.62
Analysts Strong Sell
Price Target $10.00

Company Profile

CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, develops anti-cancer drug candidates for the treatment of brain and central nervous system (CNS) tumors. The company's drug candidates include TPI 287 and Berubicin, which are in Phase 2 clinical trial for the treatment of glioblastoma and other CNS malignancies. It has license agreement with Cortice Biosciences, Inc. The company was incorporated in 2017 and is headquartered in Houston, Texas.

Industry: Biotechnology
Sector: Healthcare
Phone: 800 946 9185
Address:
2100 West Loop South, Suite 900, Houston, United States
ClarityOfPurpose2
ClarityOfPurpose2 May. 22 at 7:57 PM
$CNSP The progress made so far is that they didn’t go bankrupt or get delisted. They have enough money now to keep the lights on and pay the executive salaries and to think big thoughts for a while longer. Until the next reverse split and private placement.
0 · Reply
NetworkNewsWire
NetworkNewsWire May. 22 at 7:15 PM
Study Finds That Errors in Brain Cell Division Could Trigger Cancer $CNSP https://ibn.fm/uJ1L4 #biomed #stocks
0 · Reply
Sw1ngb0t
Sw1ngb0t May. 22 at 12:51 AM
$CNSP $VRAX weekly gap always fills... one of my new things. I really like these though
0 · Reply
30PERCENT40
30PERCENT40 May. 21 at 10:48 PM
0 · Reply
Sw1ngb0t
Sw1ngb0t May. 20 at 5:52 PM
$CNSP $2.40 then $40... you heard it here first
1 · Reply
Sw1ngb0t
Sw1ngb0t May. 20 at 2:51 PM
$CNSP let it come down to $2.40 then fill the boots
0 · Reply
VirtualInvestor
VirtualInvestor May. 20 at 1:49 PM
$CNSP CEO, Rami Levin, Participates in Virtual Investor CEO Connect Segment Highlighting Company’s Recent Strategic Transformation Progress https://vimeo.com/1193965352/6cf0543a22
0 · Reply
focafoca99
focafoca99 May. 20 at 1:11 PM
$CNSP outlined its recent $22.5 million financing and strategic transformation progress during a virtual CEO Connect segment.
0 · Reply
Sw1ngb0t
Sw1ngb0t May. 20 at 12:13 PM
$CNSP I say $4 will be a good entry... let's see
0 · Reply
Sw1ngb0t
Sw1ngb0t May. 20 at 2:17 AM
$WOK (gotta watch this one...) $CNSP $CMND $ONFO $CMND
1 · Reply
Latest News on CNSP
CNS Pharmaceuticals Quarterly report: Q1 2026

May 14, 2026, 7:00 AM EDT - 8 days ago

CNS Pharmaceuticals Quarterly report: Q1 2026


CNS Pharmaceuticals Earnings release: Q1 2026

May 14, 2026, 7:00 AM EDT - 8 days ago

CNS Pharmaceuticals Earnings release: Q1 2026


3 Penny Stocks to Watch Now, 5/5/26

2026-05-05T16:22:32.000Z - 17 days ago

3 Penny Stocks to Watch Now, 5/5/26

ELPW PN


Why Is CNS Pharmaceuticals Stock (CNSP) Up Today?

2026-05-04T13:58:45.000Z - 18 days ago

Why Is CNS Pharmaceuticals Stock (CNSP) Up Today?


CNS Pharmaceuticals Slides: Investor presentation

Apr 22, 2026, 7:00 AM EDT - 4 weeks ago

CNS Pharmaceuticals Slides: Investor presentation


CNS Pharmaceuticals Annual report: Q4 2025

Mar 31, 2026, 7:00 AM EDT - 7 weeks ago

CNS Pharmaceuticals Annual report: Q4 2025


CNS Pharmaceuticals launches new corporate growth strategy

2026-03-11T12:52:04.000Z - 2 months ago

CNS Pharmaceuticals launches new corporate growth strategy


CNS Pharmaceuticals appoints Lynne Kelley as CMO

2026-03-02T13:42:54.000Z - 2 months ago

CNS Pharmaceuticals appoints Lynne Kelley as CMO


CNS Pharmaceuticals Issues Letter to Shareholders

Jan 27, 2026, 9:00 AM EST - 4 months ago

CNS Pharmaceuticals Issues Letter to Shareholders


CNS Pharmaceuticals Inc trading resumes

2026-01-15T14:45:16.000Z - 4 months ago

CNS Pharmaceuticals Inc trading resumes


CNS Pharmaceuticals Announces CEO Transition

Dec 17, 2025, 7:00 AM EST - 5 months ago

CNS Pharmaceuticals Announces CEO Transition


CNS Pharmaceuticals sees cash runway into 2H26

2025-11-17T14:01:42.000Z - 6 months ago

CNS Pharmaceuticals sees cash runway into 2H26


CNS Pharmaceuticals Quarterly report: Q3 2025

Nov 14, 2025, 4:00 PM EST - 6 months ago

CNS Pharmaceuticals Quarterly report: Q3 2025


CNS Pharmaceuticals Proxy statement: Proxy Filing

Nov 12, 2025, 7:00 AM EST - 6 months ago

CNS Pharmaceuticals Proxy statement: Proxy Filing


CNS Pharmaceuticals Proxy statement: Proxy Filing

Oct 24, 2025, 8:00 AM EDT - 7 months ago

CNS Pharmaceuticals Proxy statement: Proxy Filing


CNS Pharmaceuticals Proxy statement: Proxy Filing

Oct 10, 2025, 8:00 AM EDT - 8 months ago

CNS Pharmaceuticals Proxy statement: Proxy Filing


CNS Pharmaceuticals upgraded to Buy at Maxim on TPI-287 roadmap

2025-09-12T13:05:32.000Z - 9 months ago

CNS Pharmaceuticals upgraded to Buy at Maxim on TPI-287 roadmap


CNS Pharmaceuticals upgraded to Buy from Hold at Maxim

2025-09-12T11:50:09.000Z - 9 months ago

CNS Pharmaceuticals upgraded to Buy from Hold at Maxim


CNS Pharmaceuticals sees cash runway into 2H26

2025-08-15T12:10:34.000Z - 10 months ago

CNS Pharmaceuticals sees cash runway into 2H26


CNS Pharmaceuticals Earnings release: Q2 2025

Aug 14, 2025, 7:00 AM EDT - 10 months ago

CNS Pharmaceuticals Earnings release: Q2 2025


CNS Pharmaceuticals Quarterly report: Q2 2025

Aug 14, 2025, 7:00 AM EDT - 10 months ago

CNS Pharmaceuticals Quarterly report: Q2 2025


CNS Pharmaceuticals Announces Reverse Stock Split

Jul 18, 2025, 8:00 AM EDT - 11 months ago

CNS Pharmaceuticals Announces Reverse Stock Split


CNS Pharmaceuticals Quarterly report: Q1 2025

May 15, 2025, 4:00 PM EDT - 1 year ago

CNS Pharmaceuticals Quarterly report: Q1 2025


CNS Pharmaceuticals Earnings release: Q4 2024

Apr 1, 2025, 4:00 PM EDT - 1 year ago

CNS Pharmaceuticals Earnings release: Q4 2024


CNS Pharmaceuticals Annual report: Q4 2024

Apr 1, 2025, 4:00 PM EDT - 1 year ago

CNS Pharmaceuticals Annual report: Q4 2024


CNS Pharmaceuticals Reports Full Year 2024 Financial Results

Apr 1, 2025, 8:05 AM EDT - 1 year ago

CNS Pharmaceuticals Reports Full Year 2024 Financial Results


CNS Pharmaceuticals Transcript: Investor Update

Dec 11, 2024, 11:30 AM EST - 1 year ago

CNS Pharmaceuticals Transcript: Investor Update


CNS Pharmaceuticals Proxy statement: Proxy Filing

Nov 15, 2024, 7:00 AM EST - 1 year ago

CNS Pharmaceuticals Proxy statement: Proxy Filing


CNS Pharmaceuticals Quarterly report: Q3 2024

Nov 14, 2024, 4:00 PM EST - 1 year ago

CNS Pharmaceuticals Quarterly report: Q3 2024


CNS Pharmaceuticals Proxy statement: Proxy Filing

Oct 28, 2024, 8:00 AM EDT - 1 year ago

CNS Pharmaceuticals Proxy statement: Proxy Filing


CNS Pharmaceuticals Proxy statement: Proxy Filing

Oct 15, 2024, 8:00 AM EDT - 1 year ago

CNS Pharmaceuticals Proxy statement: Proxy Filing


CNS Pharmaceuticals Transcript: Virtual Investor CEO Connect

Aug 26, 2024, 12:00 PM EDT - 1 year ago

CNS Pharmaceuticals Transcript: Virtual Investor CEO Connect


CNS Pharmaceuticals Quarterly report: Q2 2024

Aug 13, 2024, 6:00 PM EDT - 1 year ago

CNS Pharmaceuticals Quarterly report: Q2 2024


CNS Pharmaceuticals Transcript: Investor Update

Jul 30, 2024, 8:30 AM EDT - 1 year ago

CNS Pharmaceuticals Transcript: Investor Update


CNS Pharmaceuticals Press release: Investor Update

Jul 30, 2024, 8:30 AM EDT - 1 year ago

CNS Pharmaceuticals Press release: Investor Update


CNS Pharmaceuticals Registration statement: Registration Filing

Jul 19, 2024, 8:00 AM EDT - 2 years ago

CNS Pharmaceuticals Registration statement: Registration Filing


CNS Pharmaceuticals Registration statement: Registration Filing

Jul 12, 2024, 8:00 AM EDT - 2 years ago

CNS Pharmaceuticals Registration statement: Registration Filing


CNS Pharmaceuticals Registration statement: Registration Filing

Jun 10, 2024, 8:00 AM EDT - 2 years ago

CNS Pharmaceuticals Registration statement: Registration Filing


CNS Pharmaceuticals Quarterly report: Q1 2024

May 16, 2024, 8:00 AM EDT - 2 years ago

CNS Pharmaceuticals Quarterly report: Q1 2024


CNS Pharmaceuticals Earnings release: Q1 2024

May 16, 2024, 8:00 AM EDT - 2 years ago

CNS Pharmaceuticals Earnings release: Q1 2024


ClarityOfPurpose2
ClarityOfPurpose2 May. 22 at 7:57 PM
$CNSP The progress made so far is that they didn’t go bankrupt or get delisted. They have enough money now to keep the lights on and pay the executive salaries and to think big thoughts for a while longer. Until the next reverse split and private placement.
0 · Reply
NetworkNewsWire
NetworkNewsWire May. 22 at 7:15 PM
Study Finds That Errors in Brain Cell Division Could Trigger Cancer $CNSP https://ibn.fm/uJ1L4 #biomed #stocks
0 · Reply
Sw1ngb0t
Sw1ngb0t May. 22 at 12:51 AM
$CNSP $VRAX weekly gap always fills... one of my new things. I really like these though
0 · Reply
30PERCENT40
30PERCENT40 May. 21 at 10:48 PM
0 · Reply
Sw1ngb0t
Sw1ngb0t May. 20 at 5:52 PM
$CNSP $2.40 then $40... you heard it here first
1 · Reply
Sw1ngb0t
Sw1ngb0t May. 20 at 2:51 PM
$CNSP let it come down to $2.40 then fill the boots
0 · Reply
VirtualInvestor
VirtualInvestor May. 20 at 1:49 PM
$CNSP CEO, Rami Levin, Participates in Virtual Investor CEO Connect Segment Highlighting Company’s Recent Strategic Transformation Progress https://vimeo.com/1193965352/6cf0543a22
0 · Reply
focafoca99
focafoca99 May. 20 at 1:11 PM
$CNSP outlined its recent $22.5 million financing and strategic transformation progress during a virtual CEO Connect segment.
0 · Reply
Sw1ngb0t
Sw1ngb0t May. 20 at 12:13 PM
$CNSP I say $4 will be a good entry... let's see
0 · Reply
Sw1ngb0t
Sw1ngb0t May. 20 at 2:17 AM
$WOK (gotta watch this one...) $CNSP $CMND $ONFO $CMND
1 · Reply
SQUEAKSBANDIT
SQUEAKSBANDIT May. 18 at 11:01 AM
$ARTL watch out for armistice they are a self proclaimed long/short fund look what they have done to $CNSP on a 5 yr chart reversed 1/900,000 its toxic vulture finance they make $$$ when the stock goes down
1 · Reply
ClarityOfPurpose2
ClarityOfPurpose2 May. 14 at 10:58 PM
$CNSP You have to wonder whether the same people who gave them the private placement money also helped to subsequently pump the price, then sold their positions, and now are shorting the stock.
0 · Reply
NetworkNewsWire
NetworkNewsWire May. 14 at 7:55 PM
Study Suggests Testosterone Slows Glioblastoma Progression in Men $CNSP https://ibn.fm/l1qGw #biomed #stocks
0 · Reply
NetworkNewsWire
NetworkNewsWire May. 14 at 7:01 PM
MissionIRNewsBreaks – $CNSP Reports First-Quarter 2026 Results, Advances Strategic Transformation https://ibn.fm/jkNMs
0 · Reply
SQUEAKSBANDIT
SQUEAKSBANDIT May. 13 at 8:58 PM
$CNSP i hope you get the rip you are looking for this one is toxic though, it will go much lower just look at the history
0 · Reply
kl7777
kl7777 May. 12 at 4:45 PM
$CNSP Smaller volume today so far. But, 0 shares to short ~ 867% short borrow fee(CTB), 13 min ago
1 · Reply
Sw1ngb0t
Sw1ngb0t May. 12 at 12:19 PM
$CNSP looking primed
0 · Reply
NMWOLF
NMWOLF May. 12 at 5:16 AM
$CNSP interesting $HAO Oversold $LEDS Hot and this can fly
0 · Reply
kl7777
kl7777 May. 11 at 7:48 PM
$CNSP Short shares: 5,000 CTB(borrow fee) : 867%, 15 min ago
0 · Reply
Himan93
Himan93 May. 11 at 7:06 PM
0 · Reply
kl7777
kl7777 May. 8 at 5:36 PM
$CNSP Need more volume to move back to $15. A new post today on company's X account @cns_pharma, "advancing strategy w/ purpose together."
0 · Reply
Helpanyone
Helpanyone May. 7 at 7:20 PM
$CNSP lowering the bid not going to keep working !!! Going to be caught offside soon!!
0 · Reply